1788.TWO · HCI
Taiwan · RS rating 49 · As of 2026-10-08
| Price | 127.50 TWD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 45 / 56 / 46 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 26 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -2.1% |
| Sales growth Q/Q | -3.3% |
| Distance from 52-week high | +8.3% |
| Market cap (USD) | $178.5M |